GT BioPharma Reports Third Quarter 2021 Financial Results and Provides Corporate Update

BEVERLY HILLS, Calif.: BEVERLY HILLS, Calif., Nov. 10, 2021 /PRNewswire/ -- GT Biopharma, Inc. (the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary natural killer (NK) cell engager, TriKE platform, today announced third quarter 2021 results for the period ended...

Click to view original post